243 related articles for article (PubMed ID: 1374026)
1. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator.
Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G
Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026
[TBL] [Abstract][Full Text] [Related]
2. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
Fowler B; Mackman N; Parmer RJ; Miles LA
Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
[TBL] [Abstract][Full Text] [Related]
3. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface.
Wolf BB; Gibson CA; Kapur V; Hussaini IM; Musser JM; Gonias SL
J Biol Chem; 1994 Dec; 269(48):30682-7. PubMed ID: 7982988
[TBL] [Abstract][Full Text] [Related]
4. The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants.
Behrendt N; Rønne E; Ploug M; Petri T; Løber D; Nielsen LS; Schleuning WD; Blasi F; Appella E; Danø K
J Biol Chem; 1990 Apr; 265(11):6453-60. PubMed ID: 2156852
[TBL] [Abstract][Full Text] [Related]
5. A 55,000-60,000 Mr receptor protein for urokinase-type plasminogen activator. Identification in human tumor cell lines and partial purification.
Nielsen LS; Kellerman GM; Behrendt N; Picone R; Danø K; Blasi F
J Biol Chem; 1988 Feb; 263(5):2358-63. PubMed ID: 2828365
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens.
Reuning U; Bang NU
Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097
[TBL] [Abstract][Full Text] [Related]
8. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells.
Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM
Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.
Hajjar KA; Hamel NM
J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465
[TBL] [Abstract][Full Text] [Related]
10. Bovine urokinase-type plasminogen activator and its receptor: cloning and induction by retinoic acid.
Krätzschmar J; Haendler B; Kojima S; Rifkin DB; Schleuning WD
Gene; 1993 Mar; 125(2):177-83. PubMed ID: 8385052
[TBL] [Abstract][Full Text] [Related]
11. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex.
Heegaard CW; Simonsen AC; Oka K; Kjøller L; Christensen A; Madsen B; Ellgaard L; Chan L; Andreasen PA
J Biol Chem; 1995 Sep; 270(35):20855-61. PubMed ID: 7657671
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of urokinase-type plasminogen activator, type-1 plasminogen-activator inhibitor, urokinase receptor and alpha(2)-macroglobulin receptor in human breast carcinomas.
Christensen L; Wiborg Simonsen AC; Heegaard CW; Moestrup SK; Andersen JA; Andreasen PA
Int J Cancer; 1996 May; 66(4):441-52. PubMed ID: 8635858
[TBL] [Abstract][Full Text] [Related]
13. Identification of urokinase-type plasminogen activator receptor in human endothelial cells and its modulation by phorbol myristate acetate.
Matsumoto H; Ueshima S; Fukao H; Mitsui Y; Matsuo O
Cell Struct Funct; 1995 Dec; 20(6):429-37. PubMed ID: 8825063
[TBL] [Abstract][Full Text] [Related]
14. N-linked glycosylation of the ligand-binding domain of the human urokinase receptor contributes to the affinity for its ligand.
Møller LB; Pöllänen J; Rønne E; Pedersen N; Blasi F
J Biol Chem; 1993 May; 268(15):11152-9. PubMed ID: 8388383
[TBL] [Abstract][Full Text] [Related]
15. The N-terminal domain of human urokinase receptor contains two distinct regions critical for ligand recognition.
Pöllänen JJ
Blood; 1993 Nov; 82(9):2719-29. PubMed ID: 8219225
[TBL] [Abstract][Full Text] [Related]
16. Expression of urokinase plasminogen activator receptor in resting and activated bovine neutrophils.
Politis I; Zavizjon B; Cheli F; Baldi A
J Dairy Res; 2002 May; 69(2):195-204. PubMed ID: 12222798
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the endothelial cell urokinase-type plasminogen activator receptor. Evidence for cyclic AMP-dependent and protein kinase C-dependent pathways.
Langer DJ; Kuo A; Kariko K; Ahuja M; Klugherz BD; Ivanics KM; Hoxie JA; Williams WV; Liang BT; Cines DB
Circ Res; 1993 Feb; 72(2):330-40. PubMed ID: 7678205
[TBL] [Abstract][Full Text] [Related]
18. Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas.
Lau HK; Kim M; Koo J; Chiu B; Murray D
Clin Exp Metastasis; 1995 Nov; 13(6):492-8. PubMed ID: 7586807
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of urokinase receptor-deficient mice.
Dewerchin M; Nuffelen AV; Wallays G; Bouché A; Moons L; Carmeliet P; Mulligan RC; Collen D
J Clin Invest; 1996 Feb; 97(3):870-8. PubMed ID: 8609247
[TBL] [Abstract][Full Text] [Related]
20. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
